Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Post by indaknownewfieon Feb 19, 2020 2:42pm
159 Views
Post# 30709571

Lying on Bullboards

Lying on BullboardsFolks, So just to put it out there. TSX in NOT investigating Kalytera, Salzman, Talent or CEO Farrell for collusion and/or fraud. Just contact them because I did. Secondly, I have spoken to Mr. Farrell on two separate occasions in the past few weeks, the latest being yesterday. He was congenial but obviously he was non-committal and repeated several times that he just was not able to comment on a number of things because he did not want to get into trouble with regulators. For those that do not know, Rob Farrell is a lawyer as well and knows full the implications of sharing what he cannot and is not supposed to do. As for the stock. I am heavily invested and have been for three yrs. I continue to add where and when I have the means. The most important thing for newcomers to understand is...is the science there? Well, the answer quite simply is yes it is. Mr. Farrell has an impressive track record in the past of finding the financing to see these things through and I believe this is no exception. Do not simply look at stockhouse bullboards and accept that as your due diligence. Delve deeper and you will know whether this is the right stock for you or not. I know I have. GLTA
Bullboard Posts